Grifols

(NASDAQ) GRFS

Current Price$8.20

Market Cap$2.13B

Since IPO (2011)+43%

5 Year-51%

1 Year+21%

1 Month+3%

Grifols Financials at a Glance

Market Cap

$2.13B

Revenue (TTM)

$7.51B

Net Income (TTM)

$401.08M

EPS (TTM)

$0.67

P/E Ratio

12.23

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$8.20

Volume

953

Open

$8.18

Price

$8.20

Volume

953

Open

$8.18

Previous Close

$8.24

Daily Range

$8.18 - $8.21

52-Week Range

$7.08 - $11.14

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$8.20

Volume

953

Open

$8.18

Previous Close

$8.24

Daily Range

$8.18 - $8.21

52-Week Range

$7.08 - $11.14

GRFS News

Physician monitoring patients onscreen vitals

Is Rigel Pharmaceuticals Stock a Buy?

David HaenDec 11, 2019

Is This Overlooked Stock Primed for More Growth?

Stephen D. SimpsonMar 25, 2014

3 Stocks Set to Beat the S&P Today

Karl LoomesJul 24, 2012

Page 1

GRFS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Grifols

Industry

Biotechnology

Sector

Health Care

Employees

25,258

CEO

Nacho Abia Buenache, MBA

Website

www.grifols.com

Headquarters

Barcelona, 08174, ES

GRFS Financials

Key Financial Metrics (TTM)

Gross Margin

38%

Operating Margin

17%

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

8.18%

Dividend Yield

0.00%

Payout Ratio

31.85%

Stock Overview

Market Cap

$2.13B

Shares Outstanding

258.22M

Volume

953

Avg. Volume

745.74K

Financials (TTM)

Gross Profit

$2.58B

Operating Income

$1.19B

EBITDA

$1.62B

Operating Cash Flow

$1.01B

Capital Expenditure

$254.54M

Free Cash Flow

$751.14M

Cash & ST Invst.

$824.65M

Total Debt

$8.74B

Grifols Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.96B

-0.6%

Gross Profit

$680.40M

-11.2%

Gross Margin

34.66%

N/A

Market Cap

$2.13B

N/A

Market Cap/Employee

$89.28K

N/A

Employees

23,833

N/A

Net Income

$97.33M

+41.1%

EBITDA

$395.71M

+17.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$7.92B

+12.9%

Accounts Receivable

$844.64M

-21.7%

Inventory

$3.29B

-7.5%

Long Term Debt

$8.35B

-11.6%

Short Term Debt

$385.84M

-39.7%

Return on Assets

2.04%

N/A

Return on Invested Capital

7.21%

N/A

Free Cash Flow

$335.21M

-19.1%

Operating Cash Flow

$418.64M

-18.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CORTCorcept Therapeutics Incorporated

CORTCorcept Therapeutics Incorporated$50.05+7.58%

AVTRAvantor, Inc.

AVTRAvantor, Inc.$7.96-1.79%

BIOBio-Rad Laboratories, Inc.

BIOBio-Rad Laboratories, Inc.$251.67-10.16%

HALOHalozyme Therapeutics, Inc.

HALOHalozyme Therapeutics, Inc.$63.58-0.13%

ATRAptarGroup, Inc.

ATRAptarGroup, Inc.$119.10-3.70%

HSICHenry Schein, Inc.

HSICHenry Schein, Inc.$74.45-0.19%

MASIMasimo Corporation

MASIMasimo Corporation$178.47+0.02%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.22+0.06%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.65+0.00%

RBLXRoblox

RBLXRoblox$46.90-0.15%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.01-0.03%

AALAmerican Airlines Group

AALAmerican Airlines Group$11.94+0.02%

MARAMara Holdings

MARAMara Holdings$11.82-0.01%

RIVNRivian Automotive

RIVNRivian Automotive$15.31-0.07%

Questions About GRFS

What is the current price of Grifols?

Grifols is trading at $8.20 per share.

What is the 52-week range for Grifols?

Over the past 52 weeks, Grifols has traded between $7.08 and $11.14.

How much debt does Grifols have?

As of the most recent reporting period, Grifols reported total debt of $10.27B.

How much cash does Grifols have on hand?

Grifols reported $968.92M in cash and cash equivalents in its most recent financial results.

What is Grifols’s dividend yield?

Grifols does not currently have a dividend yield.

Grifols

Grifols Financials at a Glance

GRFS News

Why Shares of Grifols Were Up Tuesday

2 Healthcare Stocks That Could Help Make You a Fortune

Convalescent Plasma Found to Reduce COVID-19 Death Rate in New Study

Better Coronavirus Stock: Grifols or Novartis?

Who Can Donate Plasma for COVID-19 Patients?

Is Rigel Pharmaceuticals Stock a Buy?

Is This Overlooked Stock Primed for More Growth?

3 Stocks Set to Beat the S&P Today

GRFS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Grifols

GRFS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Grifols Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GRFS

What is the current price of Grifols?

What is the 52-week range for Grifols?

How much debt does Grifols have?

How much cash does Grifols have on hand?

What is Grifols’s dividend yield?

Premium Investing Services